Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease.

Arias-Guillén M, Riestra S, de Francisco R, Palacios JJ, Belda J, Escalante P, Pérez-Martínez I, Molinos LM, Garcia-Clemente M, Pando-Sandoval A, Rodrigo L, Prieto A, Martínez-Camblor P, Losada A, Casan P.

Inflamm Bowel Dis. 2014 Feb;20(2):329-38. doi: 10.1097/01.MIB.0000438429.38423.62.

PMID:
24378597
2.

Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.

Vassilopoulos D, Tsikrika S, Hatzara C, Podia V, Kandili A, Stamoulis N, Hadziyannis E.

Clin Vaccine Immunol. 2011 Dec;18(12):2102-8. doi: 10.1128/CVI.05299-11. Epub 2011 Oct 12.

3.

Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Shahidi N, Fu YT, Qian H, Bressler B.

Inflamm Bowel Dis. 2012 Nov;18(11):2034-42. doi: 10.1002/ibd.22901. Epub 2012 Jan 31.

PMID:
22294550
4.

Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.

Kleinert S, Tony HP, Krueger K, Detert J, Mielke F, Rockwitz K, Schwenke R, Burmester GR, Diel R, Feuchtenberger M, Kneitz C.

Ann Rheum Dis. 2012 Nov;71(11):1791-5. doi: 10.1136/annrheumdis-2011-200941. Epub 2012 May 14.

PMID:
22586160
5.

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.

Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL; Tuberculosis Epidemiologic Studies Consortium.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):77-87. doi: 10.1164/rccm.201302-0365OC.

PMID:
24299555
6.

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.

Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF, Rook G, Zumla A, Dheda K.

BMC Pulm Med. 2010 Feb 22;10:7. doi: 10.1186/1471-2466-10-7.

7.

Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.

O'Shea MK, Fletcher TE, Beeching NJ, Dedicoat M, Spence D, McShane H, Cunningham AF, Wilson D.

PLoS One. 2014 May 9;9(5):e97366. doi: 10.1371/journal.pone.0097366. eCollection 2014.

8.

Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.

Adetifa IM, Ota MO, Jeffries DJ, Hammond A, Lugos MD, Donkor S, Patrick O, Adegbola RA, Hill PC.

Pediatr Infect Dis J. 2010 May;29(5):439-43. doi: 10.1097/INF.0b013e3181cb45da.

PMID:
20068506
9.

Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.

Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H, Godfrey-Faussett P.

PLoS One. 2011 Apr 4;6(4):e18206. doi: 10.1371/journal.pone.0018206.

10.

Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers.

Whitaker JA, Mirtskhulava V, Kipiani M, Harris DA, Tabagari N, Kempker RR, Blumberg HM.

PLoS One. 2013;8(3):e58202. doi: 10.1371/journal.pone.0058202. Epub 2013 Mar 25. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/1191cfc8-6f0f-498f-aae2-5452884615b7. A Whitaker, Jennifer [corrected to Whitaker, Jennifer A].

11.

Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.

Kruczak K, Duplaga M, Sanak M, Cmiel A, Mastalerz L, Sladek K, Nizankowska-Mogilnicka E.

Scand J Infect Dis. 2014 Sep;46(9):649-55. doi: 10.3109/00365548.2014.927955. Epub 2014 Jul 30.

PMID:
25073535
12.

Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.

Chung WK, Zheng ZL, Sung JY, Kim S, Lee HH, Choi SJ, Yang J.

Clin Microbiol Infect. 2010 Jul;16(7):960-5. doi: 10.1111/j.1469-0691.2009.02949.x. Epub 2009 Nov 10.

13.

Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.

Kim JS, Cho JH, Park GY, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.

Transplant Proc. 2013 Oct;45(8):2899-902. doi: 10.1016/j.transproceed.2013.08.059.

PMID:
24157000
14.

Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.

Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R.

Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):95-101.

PMID:
22117500
15.

Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis.

Camlar SA, Makay B, Appak O, Appak YC, Esen N, Günay T, Anal O, Unsal E.

Clin Rheumatol. 2011 Sep;30(9):1189-93. doi: 10.1007/s10067-011-1724-3. Epub 2011 Mar 15.

PMID:
21403997
16.

Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.

Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS.

J Microbiol Immunol Infect. 2014 Nov 1. pii: S1684-1182(14)00179-0. doi: 10.1016/j.jmii.2014.08.010. [Epub ahead of print]

17.

Tests for latent tuberculosis in people with ESRD: a systematic review.

Rogerson TE, Chen S, Kok J, Hayen A, Craig JC, Sud K, Kable K, Webster AC.

Am J Kidney Dis. 2013 Jan;61(1):33-43. doi: 10.1053/j.ajkd.2012.07.019. Epub 2012 Oct 13. Review.

PMID:
23068425
18.

A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.

Lucas M, Nicol P, McKinnon E, Whidborne R, Lucas A, Thambiran A, Burgner D, Waring J, French M.

Thorax. 2010 May;65(5):442-8. doi: 10.1136/thx.2009.127555.

PMID:
20435869
19.

QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy.

Saracino A, Scotto G, Fornabaio C, Martinelli D, Faleo G, Cibelli D, Tartaglia A, Di Tullio R, Fazio V, Prato R, Monno L, Angarano G.

New Microbiol. 2009 Oct;32(4):369-76.

20.

The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy.

Mantzaris GJ, Tsironikos D, Tzanetakou X, Grispou E, Karatzas P, Kalogeropoulos I, Papamichael K.

Scand J Gastroenterol. 2015;50(12):1451-5. doi: 10.3109/00365521.2015.1064470. Epub 2015 Jul 3.

PMID:
26139305
Items per page

Supplemental Content

Write to the Help Desk